PT Cipta Sarana Medika Tbk (IDX:DKHH)

IDX:DKHH Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	134,188	99,578	105,656
Revenue Growth (YoY)	34.76%	-5.75%	-
Cost of Revenue	91,669	70,105	69,119
Gross Profit	42,519	29,473	36,537
Selling, General & Admin	26,606	19,131	19,129
Other Operating Expenses	2,871	174.06	415.02
Operating Expenses	32,845	22,327	22,499
Operating Income	9,674	7,146	14,038
Interest Expense	-7,223	-3,512	-4,618
Other Non Operating Income (Expenses)	-267.52	1,072	784.19
EBT Excluding Unusual Items	2,184	4,706	10,205
Gain (Loss) on Sale of Assets	-	23.05	-
Other Unusual Items	3,032	1,379	-
Pretax Income	5,215	6,108	10,205
Income Tax Expense	1,676	1,220	2,304
Net Income	3,540	4,888	7,901
Net Income to Common	3,540	4,888	7,901
Net Income Growth	-27.59%	-38.13%	-
Shares Outstanding (Basic)	555	555	309
Shares Outstanding (Diluted)	555	555	309
Shares Change (YoY)	-	79.52%	-
EPS (Basic)	6.38	8.81	25.57
EPS (Diluted)	6.38	8.81	25.57
EPS Growth	-27.59%	-65.54%	-
Free Cash Flow	-16,411	-9,247	22,887
Free Cash Flow Per Share	-29.59	-16.67	74.07
Gross Margin	31.69%	29.60%	34.58%
Operating Margin	7.21%	7.18%	13.29%
Profit Margin	2.64%	4.91%	7.48%
Free Cash Flow Margin	-12.23%	-9.29%	21.66%
EBITDA	17,429	15,483	19,863
EBITDA Margin	12.99%	15.55%	18.80%
D&A For EBITDA	7,755	8,337	5,825
EBIT	9,674	7,146	14,038
EBIT Margin	7.21%	7.18%	13.29%
Effective Tax Rate	32.13%	19.97%	22.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.